Literature DB >> 9159234

Structure-function relationship in the IL-1 family.

D Boraschi1, P Bossu, G Macchia, P Ruggiero, A Tagliabue.   

Abstract

The interleukin 1 (IL-1) family is a group of related cytokines including two agonist proteins (IL-1alpha and IL-1beta), each derived by enzymatic cleavage of precursor proteins (pro-IL-1alpha and pro-IL-1beta), and three forms of an antagonist protein (IL-1ra, icIL-1raI, icIL-1raII). IL-1 plays a key role in the onset and development of the host reaction to invasion, being an important factor in the initiation of the inflammatory response and in the triggering of immune functions. Due to its pleiotropic activity and to the high potency of its inflammatory effects, IL-1 activity is tightly regulated in the body by a complex network of control systems. These include the presence of two types of inhibitors, the receptor antagonist IL-1ra and the second type of IL-1 receptor (IL-1RI), which is a natural scavenger of IL-1. Furthermore, regulation of IL-1 activity is attained by a strict hierarchy of binding affinity of the two receptors (the activating IL-1RI and the inhibitory IL-1RII) for the various members of the IL-1 family. Additional levels of control are represented by the presence of soluble forms of both receptors and of immature pro-IL-1 forms with different characteristics of activity and receptor binding capacity. To clarify the features of reciprocal interaction among ligands and receptors, in the attempt to understand the rules regulating the IL-1 system and its effectiveness, a deep analysis of the relationship between structure and function in the proteins of the IL-1 family becomes of key importance. Information on this line has been provided by several groups mainly with studies of mutagenesis of IL-1alpha, IL-1beta and IL-1ra in parallel with biological assays of activity. In this review, a survey of the available data is provided, in order to construct a hypothetical model of the functional structure of IL-1 proteins as a basis for future therapeutic interventions based on genetic and protein engineering.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9159234     DOI: 10.2741/a132

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  18 in total

1.  Accessory to inflammation.

Authors:  John E Sims
Journal:  Nat Immunol       Date:  2010-10       Impact factor: 25.606

2.  Design of a superior cytokine antagonist for topical ophthalmic use.

Authors:  Jinzhao Hou; Sharon A Townson; Joseph T Kovalchin; Allyson Masci; Olga Kiner; Yanqun Shu; Bracken M King; Emily Schirmer; Kathryn Golden; Christoph Thomas; K Christopher Garcia; Gregory Zarbis-Papastoitsis; Eric S Furfine; Thomas M Barnes
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-19       Impact factor: 11.205

3.  Decreased expression of the decoy interleukin-1 receptor type II in human endometriosis.

Authors:  A Akoum; C Jolicoeur; A Kharfi; M Aubé
Journal:  Am J Pathol       Date:  2001-02       Impact factor: 4.307

4.  Specific role of interleukin-1 in hepatic neutrophil recruitment after ischemia/reperfusion.

Authors:  Atsushi Kato; Cem Gabay; Tomohisa Okaya; Alex B Lentsch
Journal:  Am J Pathol       Date:  2002-11       Impact factor: 4.307

Review 5.  Structural biology of the IL-1 superfamily: key cytokines in the regulation of immune and inflammatory responses.

Authors:  Brian Krumm; Yan Xiang; Junpeng Deng
Journal:  Protein Sci       Date:  2014-03-04       Impact factor: 6.725

6.  Lipooligosaccharide and polysaccharide capsule: virulence factors of Neisseria meningitidis that determine meningococcal interaction with human dendritic cells.

Authors:  Alexandra Unkmeir; Ulrike Kämmerer; Anne Stade; Claudia Hübner; Sabine Haller; Annette Kolb-Mäurer; Matthias Frosch; Guido Dietrich
Journal:  Infect Immun       Date:  2002-05       Impact factor: 3.441

7.  Structural insights into the assembly and activation of IL-1β with its receptors.

Authors:  Dongli Wang; Senyan Zhang; Liang Li; Xi Liu; Kunrong Mei; Xinquan Wang
Journal:  Nat Immunol       Date:  2010-08-29       Impact factor: 25.606

Review 8.  Is there value in plasma cytokine measurements in patients with severe trauma and sepsis?

Authors:  Lori F Gentile; Alex G Cuenca; Erin L Vanzant; Philip A Efron; Bruce McKinley; Frederick Moore; Lyle L Moldawer
Journal:  Methods       Date:  2013-05-11       Impact factor: 3.608

9.  Immunogenicity and protection efficacy of replication-deficient influenza A viruses with altered NS1 genes.

Authors:  Boris Ferko; Jana Stasakova; Julia Romanova; Christian Kittel; Sabine Sereinig; Hermann Katinger; Andrej Egorov
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

10.  Selection of a MCF-7 Breast Cancer Cell Subpopulation with High Sensitivity to IL-1β: Characterization of and Correlation between Morphological and Molecular Changes Leading to Increased Invasiveness.

Authors:  Eloy Andres Pérez-Yépez; Jorge-Tonatiuh Ayala-Sumuano; Alicia Maria Reveles-Espinoza; Isaura Meza
Journal:  Int J Breast Cancer       Date:  2012-05-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.